Reducing Events of Noncompliance in Neurology Human Subjects Research: the Effect of Human Subjects Research Protection Training and Site Initiation Visits-Reference-Cited by-同舟云学术

Reducing Events of Noncompliance in Neurology Human Subjects Research: the Effect of Human Subjects Research Protection Training and Site Initiation Visits

Published:2021-01-21 Issue:2 Volume:18 Page:859-865
ISSN:1933-7213
Container-title:Neurotherapeutics
language:en
Short-container-title:Neurotherapeutics

Author:

Gooden Matthew J.,Norato Gina,Martin Sandra B.,Nath Avindra,Reoma Lauren

Funder

Intramural Research Program from the National Institute of Neurological Disorders and Stroke, NIH

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s13311-020-01003-4.pdf

Reference19 articles.

1. Simonato, M., Bennett, J., Boulis, N. M., et al. Progress in gene therapy for neurological disorders. Nat Rev Neurol 2013;9:277-291.

2. Tan, L., Jiang, T., Tan, L., & Yu, J. T. Toward precision medicine in neurological diseases. Ann Transl Med 2016;4:104.

3. Hall, D. A., Ramos, A. R., Gelfand, J. M., et al. The state of clinical research in neurology. Neurology 2018;90:e1347-e1354.

4. Ghooi, R. B., Bhosale, N., Wadhwani, R., Divate, P., & Divate, U. Assessment and classification of protocol deviations. Perspect Clin Res 2016;7:132–136.

5. Al-Shahi Salman, R., Beller, E., Kagan, J., Hemminki, E., Phillips, R. S., Savulescu, J., et al. Increasing value and reducing waste in biomedical research regulation and management. Lancet 2014;383:176–185.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Limits of ethical non-human subjects research in an applied setting;Accountability in Research;2024-02-18

2. Rethinking the clinical research protocol: Lessons learned from the COVID-19 pandemic and recommendations for reducing noncompliance;Clinical Trials;2024-02-17

3. The Practice of Experimental Neurotherapeutics in Neuromuscular Disease;CONTINUUM: Lifelong Learning in Neurology;2022-12